Duo Yu

745 total citations · 1 hit paper
27 papers, 561 citations indexed

About

Duo Yu is a scholar working on Molecular Biology, Civil and Structural Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Duo Yu has authored 27 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Civil and Structural Engineering and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Duo Yu's work include Nanoplatforms for cancer theranostics (6 papers), Structural Analysis and Optimization (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Duo Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Structural Analysis and Optimization (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Duo Yu collaborates with scholars based in China. Duo Yu's co-authors include Tiejun Wang, Xueshibojie Liu, E Changyong, Shan Yu, Yunhe Fu, Caijun Zhao, Naisheng Zhang, Zhuoyu Liu, Zhaoqi He and Lianjun Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Duo Yu

25 papers receiving 556 citations

Hit Papers

Endoplasmic reticulum stress-mediated autophagy activatio... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duo Yu China 12 268 163 136 55 53 27 561
Yue Yang China 13 200 0.7× 62 0.4× 63 0.5× 48 0.9× 17 0.3× 81 580
Huasheng Zhang China 14 205 0.8× 37 0.2× 76 0.6× 12 0.2× 80 1.5× 48 696
Satoshi Fujiwara Japan 11 125 0.5× 93 0.6× 68 0.5× 87 1.6× 11 0.2× 30 490
Chenyao Li China 16 465 1.7× 233 1.4× 39 0.3× 20 0.4× 36 0.7× 41 688
Li Xiong China 16 742 2.8× 549 3.4× 48 0.4× 27 0.5× 87 1.6× 42 1.1k
Zhao Ding China 11 142 0.5× 42 0.3× 37 0.3× 21 0.4× 62 1.2× 40 390
Tingyue Zhang China 10 287 1.1× 108 0.7× 32 0.2× 40 0.7× 46 0.9× 19 703
Ruling Zhang China 13 150 0.6× 64 0.4× 31 0.2× 19 0.3× 70 1.3× 20 511

Countries citing papers authored by Duo Yu

Since Specialization
Citations

This map shows the geographic impact of Duo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duo Yu more than expected).

Fields of papers citing papers by Duo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duo Yu. The network helps show where Duo Yu may publish in the future.

Co-authorship network of co-authors of Duo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Duo Yu. A scholar is included among the top collaborators of Duo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duo Yu. Duo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Qinghe, et al.. (2025). Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment. Materials Today Bio. 31. 101601–101601. 6 indexed citations
2.
Zhao, Beibei, Jiaxin Shi, Yang Xiao, et al.. (2025). Research progress on the mechanism and treatment of cachexia based on tumor microenvironment. Nutrition. 133. 112697–112697. 1 indexed citations
3.
Yuan, Liang, Pengye Du, Yi Wei, et al.. (2025). Engineering ferroptosis radiosensitizer for SPARC-targeted degradation: A strategy to reverse radioresistant non-small cell lung cancer. Biomaterials. 326. 123675–123675. 1 indexed citations
4.
Yu, Duo, et al.. (2025). Topology optimization method of truss structures considering length constraints. Structures. 77. 109079–109079. 1 indexed citations
5.
Yu, Duo, et al.. (2025). Advances in the combination of immunoadjuvants and tumor ablation: Mediating immune effects to enhance anti-tumor efficacy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189393–189393.
6.
Zhang, Wangqian, Fei Xie, Jiaxin Shi, et al.. (2025). GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinoma. Cell Communication and Signaling. 23(1). 440–440.
7.
Yuan, Liang, et al.. (2024). Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy. Coordination Chemistry Reviews. 520. 216140–216140. 5 indexed citations
8.
Gao, Hui, Mingwei Wang, Duo Yu, et al.. (2024). The transcription factor GATA3 positively regulates NRP1 to promote radiation-induced pulmonary fibrosis. International Journal of Biological Macromolecules. 262(Pt 2). 130052–130052. 5 indexed citations
9.
Liu, Zhongshan, Yuan Liang, Pengye Du, et al.. (2024). Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy. Advanced Science. 12(7). e2407833–e2407833. 10 indexed citations
10.
Liu, Zhongshan, et al.. (2023). Recent Progress of Copper-Based Nanomaterials in Tumor-Targeted Photothermal Therapy/Photodynamic Therapy. Pharmaceutics. 15(9). 2293–2293. 18 indexed citations
11.
Yu, Duo, et al.. (2023). The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells. PLoS ONE. 18(10). e0293283–e0293283. 1 indexed citations
12.
Zhao, Zhongwei, Duo Yu, Tongrui Zhang, & Qi Cai. (2022). Intelligent design algorithm for branching structures based on updated force density method. Journal of Building Engineering. 57. 104858–104858. 12 indexed citations
13.
Zhao, Caijun, Duo Yu, Zhaoqi He, et al.. (2021). Endoplasmic reticulum stress-mediated autophagy activation is involved in cadmium-induced ferroptosis of renal tubular epithelial cells. Free Radical Biology and Medicine. 175. 236–248. 181 indexed citations breakdown →
14.
Yu, Shan, Xueshibojie Liu, Duo Yu, E Changyong, & Jinghui Yang. (2020). Piperine protects LPS-induced mastitis by inhibiting inflammatory response. International Immunopharmacology. 87. 106804–106804. 17 indexed citations
15.
Yu, Shan, Xueshibojie Liu, Duo Yu, E Changyong, & Jinghui Yang. (2020). Morin Protects LPS-Induced Mastitis via Inhibiting NLRP3 Inflammasome and NF-κB Signaling Pathways. Inflammation. 43(4). 1293–1303. 43 indexed citations
16.
Liu, Xueshibojie, et al.. (2019). Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice. International Immunopharmacology. 76. 105886–105886. 35 indexed citations
17.
Yang, Jinghui, Duo Yu, Xueshibojie Liu, E Changyong, & Shan Yu. (2019). LncRNA PCED1B‐AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR‐194‐5p/PCED1B axis. Journal of Cellular Biochemistry. 121(2). 1823–1833. 27 indexed citations
18.
Yu, Duo, Yunfeng Li, Zhi‐Hui Ming, et al.. (2018). Comprehensive circular RNA expression profile in radiation-treated HeLa cells and analysis of radioresistance-related circRNAs. PeerJ. 6. e5011–e5011. 55 indexed citations
19.
Yu, Duo, et al.. (2011). Improvement of Hood Hinge Based on Protection of Pedestrian Head. Advanced materials research. 228-229. 119–124. 1 indexed citations
20.
Wang, Yu, Ying Lü, Duo Yu, et al.. (2008). Enhanced Resistance of Restraint-Stressed Mice to Sepsis. The Journal of Immunology. 181(5). 3441–3448. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026